- Home
- INO vs EPM Comparison
INO vs EPM Comparison
Compare INO & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- EPM
- Stock Information
- Founded
- INO 1979
- EPM 2003
- Country
- INO United States
- EPM United States
- Employees
- INO N/A
- EPM N/A
- Industry
- INO Medical/Dental Instruments
- EPM Oil & Gas Production
- Sector
- INO Health Care
- EPM Energy
- Exchange
- INO Nasdaq
- EPM Nasdaq
- Market Cap
- INO 136.6M
- EPM 154.4M
- IPO Year
- INO 1998
- EPM 1996
- Fundamental
- Price
- INO $1.77
- EPM $3.74
- Analyst Decision
- INO Buy
- EPM Hold
- Analyst Count
- INO 5
- EPM 1
- Target Price
- INO $9.00
- EPM $4.50
- AVG Volume (30 Days)
- INO 1.4M
- EPM 361.2K
- Earning Date
- INO 11-10-2025
- EPM 11-11-2025
- Dividend Yield
- INO N/A
- EPM 12.44%
- EPS Growth
- INO N/A
- EPM N/A
- EPS
- INO N/A
- EPM N/A
- Revenue
- INO $182,337.00
- EPM $85,232,000.00
- Revenue This Year
- INO N/A
- EPM N/A
- Revenue Next Year
- INO $14,751.49
- EPM $1.13
- P/E Ratio
- INO N/A
- EPM N/A
- Revenue Growth
- INO N/A
- EPM N/A
- 52 Week Low
- INO $1.30
- EPM $3.86
- 52 Week High
- INO $4.61
- EPM $6.14
- Technical
- Relative Strength Index (RSI)
- INO 31.56
- EPM 20.33
- Support Level
- INO $1.93
- EPM $4.35
- Resistance Level
- INO $2.11
- EPM $4.60
- Average True Range (ATR)
- INO 0.14
- EPM 0.13
- MACD
- INO -0.05
- EPM -0.05
- Stochastic Oscillator
- INO 0.43
- EPM 2.81
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.